Artificially sweetened beverage consumption and all-cause and cause-specific mortality: an updated systematic review and dose-response meta-analysis of prospective cohort studies

Author:

Chen Zhangling,Wei Cheng,Lamballais Sander,Wang Kang,Mou Yuchan,Xiao Yichao,Luo Fei,Bramer Wichor M.,Voortman Trudy,Zhou Shenghua

Abstract

Abstract Background Artificially sweetened beverages (ASB) are consumed globally, but their impact on overall health remains uncertain. We summarized published associations between ASB intake with all-cause and cause-specific mortality. Methods We searched Medline, Embase, Web of Science, and Cochrane CENTRAL databases until August 2023. Random effect meta-analysis was conducted to calculate pooled risk ratios (RRs) and 95% confidence intervals (95%CIs) for highest versus lowest categories of ASB consumption in relation to all-cause and cause-specific mortality. Linear and non-linear dose-response analyses were also performed. Results Our systematic review and meta-analysis included 11 prospective cohort studies. During a median/mean follow-up period of 7.0 to 28.9 years, 235,609 deaths occurred among 2,196,503 participants. Intake of ASB was associated with higher risk of all-cause and CVD mortality with pooled RRs (95%CIs) of highest vs. lowest intake categories of 1.13 (1.06, 1.21) (I2 = 66.3%) for all-cause mortality and 1.26 (1.10, 1.44) (I2 = 52.0%) for CVD mortality. Dose-response analysis revealed a non-linear association of ASB with all-cause mortality (pnon−linearity = 0.01), but a linear positive association with CVD mortality (pnon−linearity = 0.54). No significant association was observed for ASB intake and cancer mortality. Moreover, a secondary meta-analysis demonstrated that replacing 1 serving/day of sugary sweetened beverages (SSB) with ASB was associated with 4–6% lower risk of all-cause and CVD mortality. Per NutriGrade, the evidence quality for associations between ASB intake with all-cause and CVD mortality was moderate. Conclusions Higher intake of ASB was associated with higher risk of all-cause and CVD mortality, albeit a lower risk than for SSB. Systematic review registration PROSPERO registration no. CRD42022365701.

Funder

National Natural Science Foundation of China

Scientific Research Program of FuRong Laboratory

Publisher

Springer Science and Business Media LLC

Reference39 articles.

1. Khan TA, et al. Relation of total sugars, sucrose, Fructose, and added sugars with the risk of Cardiovascular Disease: a systematic review and dose-response Meta-analysis of prospective cohort studies. Mayo Clin Proc. 2019;94(12):2399–414.

2. WHO. Guideline: Sugars intake for adult and children. Geneva: World Health Organizationhttp://public.eblib.com/choice/publicfullrecord.aspx?p=2033879, 2015.

3. Bachmanov AA, et al. Genetics of sweet taste preferences. Flavour Fragr J. 2011;26(4):286–94.

4. Rios-Leyvraz M. M.J., Health effects of the use of non-sugar sweeteners: a systematic review and meta-analysis. Geneva: World Health Organizationhttps://www.who.int/publications/i/item/9789240046429, 2022.

5. Patel L, Alicandro G, Vecchia CL. Low-calorie Beverage Consumption, Diet Quality and Cardiometabolic Risk factors in British adults. Nutrients, 2018. 10(9).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3